Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_assertion type Assertion NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_head.
- NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_provenance.
- NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_assertion evidence source_evidence_literature NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_provenance.
- NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_assertion SIO_000772 23948998 NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_provenance.
- NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_assertion wasDerivedFrom befree-20150227 NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_provenance.
- NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_assertion wasGeneratedBy ECO_0000203 NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_provenance.